Renal Injury Repair: How About the Role of Stem Cells
Renal failure is one of the most important causes of mortality and morbidity all over the world. Acute kidney injury (AKI) is a major clinical problem that affects up to 5% of all hospitalized patients. Although the kidney has a remarkable capacity for regeneration after acute injury, the mortality among patients with severe AKI remains dismally high, and in clinical practice, most patients cannot be cured completely and suffer from chronic kidney disease (CKD). Recently, the incidence and prevalence of CKD have increased, largely as a result of the enhanced prevalence of diabetes and obesity. The progressive nature of CKD and the ensuing end-stage renal disease (ESRD) place a substantial burden on global healthcare resources. Currently, dialysis and transplantation remain the only treatment options. Finding new therapeutic methods to fight AKI and CKD remains an ongoing quest. Although the human renal histological structure is complex, stem cell therapies have been applied to repair injured kidneys. The curative effects of mesenchymal stem cells (MSCs), hematopoietic stem cells (HSCs), induced pluripotent stem cells (iPSCs), and nephron progenitor cells (NPCs) on renal repair have also been reported by researchers. This review focuses on stem cell therapy and mechanisms for renal injury repair.
KeywordsStem cell Renal repair Acute kidney injury Chronic kidney disease
This study was supported by the National Natural Science Foundation of China (No. 81670616 and No. 81873598), the innovation fund for the clinical research of the Harbin Medical University (2017LCZX44).
- Jang HR, Park JH, Kwon GY, Lee JE, Huh W, Jin HJ et al (2014) Effect of preemptive treatment with human umbilical cord blood-derived mesenchymal stem cells on the development of renal ischemia-reperfusion injury in mice. Am J Physiol Renal Physiol 307:F1149–F1161PubMedCrossRefPubMedCentralGoogle Scholar
- Lam AQ, Freedman BS, Morizane R, Lerou PH, Valerius MT, Bonventre JV (2014) Rapid and efficient differentiation of human pluripotent stem cells into intermediate mesoderm that forms tubules expressing kidney proximal tubular markers. J Am Soc Nephrol 25:1211–1225PubMedCrossRefPubMedCentralGoogle Scholar
- Lee PY, Chien Y, Chiou GY, Lin CH, Chiou CH, Tarng DC (2012) Induced pluripotent stem cells without c-Myc attenuate acute kidney injury via downregulating the signaling of oxidative stress and inflammation in ischemia-reperfusion rats. Cell Transplant 21:2569–2585PubMedCrossRefPubMedCentralGoogle Scholar
- Migliorini A, Angelotti ML, Mulay SR, Kulkarni OO, Demleitner J, Dietrich A et al (2013) The antiviral cytokines IFN-alpha and IFN-beta modulate parietal epithelial cells and promote podocyte loss: implications for IFN toxicity, viral glomerulonephritis, and glomerular regeneration. Am J Pathol 183:431–440PubMedCrossRefPubMedCentralGoogle Scholar
- Si XY, Li JJ, Yao T, Wu XY (2014) Transforming growth factor-beta1 in the microenvironment of ischemia reperfusion-injured kidney enhances the chemotaxis of mesenchymal stem cells to stromal cell-derived factor-1 through upregulation of surface chemokine (C-X-C motif) receptor 4. Mol Med Rep 9:1794–1798PubMedCrossRefPubMedCentralGoogle Scholar
- Wise AF, Williams TM, Kiewiet MB, Payne NL, Siatskas C, Samuel CS et al (2014) Human mesenchymal stem cells alter macrophage phenotype and promote regeneration via homing to the kidney following ischemia-reperfusion injury. Am J Physiol Renal Physiol 306:F1222–F1235PubMedCrossRefPubMedCentralGoogle Scholar